Can circulating miR-7-1-5p, and miR-33a-5p be used as markers of T2D patients?

References

• Arefhosseini, S., Ebrahimi-Mamaeghani, M., and Mohammadi, S., MicroRNAs Regulation by Nutrients, the New Ray of Hope in Obesity. 2014.
   Google Scholar
• Association, A.D., 2010. Diagnosis and classification of diabetes mellitus. Diabetes Care, 33 (Supplement 1), S62–S9.
   PubMedGoogle Scholar
• Barutta, F., et al., 2018. MicroRNA and microvascular complications of diabetes. International journal of endocrinology, 2018, 6890501.
   PubMed Web of Science ®Google Scholar
• Beuzelin, D., and Kaeffer, B., 2018. Exosomes and mirna-loaded biomimetic nanovehicles, a focus on their potentials preventing type-2 diabetes linked to metabolic syndrome. Frontiers in immunology, 9, 2711.
   PubMed Web of Science ®Google Scholar
• Chakraborty, C., et al., 2014. Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes. Wiley interdiscip rev RNA, 5 (5), 697–712.
   PubMed Web of Science ®Google Scholar
• Chen, W.M., et al., 2016. Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins. Plos one, 11 (5), e0154672.
   PubMed Web of Science ®Google Scholar
• Correa-Medina, M., et al., 2009. MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene expression patterns: Gep, 9 (4), 193–199.
   PubMed Web of Science ®Google Scholar
• Davalos, A., et al., 2011. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proceedings of the national academy of sciences of the United States of America, 108 (22), 9232–9237.
   PubMed Web of Science ®Google Scholar
• Deng, X., et al., 2018. B-RCA revealed circulating miR-33a/b associates with serum cholesterol in type 2 diabetes patients at high risk of ASCVD. Diabetes research and clinical practice, 140, 191–199.
   PubMed Web of Science ®Google Scholar
• Guay, C., and Regazzi, R., 2013. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nature reviews. endocrinology, 9 (9), 513–521.
   PubMed Web of Science ®Google Scholar
• Horie, T., et al., 2010. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proceedings of the national academy of sciences of the United States of America, 107 (40), 17321–17326.
   PubMed Web of Science ®Google Scholar
• Horsham, J.L., et al., 2015. MicroRNA-7: A miRNA with expanding roles in development and disease. The international journal of biochemistry and cell biology, 69, 215–224.
   PubMed Web of Science ®Google Scholar
• Kharroubi, A.T., and Darwish, H.M., 2015. Diabetes mellitus: The epidemic of the century. World journal of diabetes, 6 (6), 850–867.
   PubMed Web of Science ®Google Scholar
• Kredo-Russo, S., et al., 2012. Regulation of pancreatic microRNA-7 expression. Experimental diabetes research, 2012, 695214–22675342.
   PubMedGoogle Scholar
• Luo, M., et al., 2019. Circulating miR-30c as a predictive biomarker of type 2 diabetes mellitus with coronary heart disease by regulating PAI-1/VN interactions. Life sciences, 239, 117092.
   PubMed Web of Science ®Google Scholar
• Magliano, D.J., et al., 2019. Trends in incidence of total or type 2 diabetes: systematic review. BMJ (Clinical Research ed.).), 366, l5003.
   PubMedGoogle Scholar
• Mambiya, M., et al., 2019. The play of genes and non-genetic factors on type 2 diabetes. Frontiers in public health, 7, 349.
   PubMed Web of Science ®Google Scholar
• Ogurtsova, K., et al., 2017. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice, 128, 40–50.
   PubMed Web of Science ®Google Scholar
• Rayner, K.J., et al., 2011. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature, 478 (7369), 404–407.
   PubMed Web of Science ®Google Scholar
• Rottiers, V., et al., 2013. Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR. Science translational medicine, 5 (212), 212ra162.
   PubMed Web of Science ®Google Scholar
• Shahrokhi, S.Z., et al., 2020. Can miR-145-5p be used as a marker in diabetic patients? Archives of physiology and biochemistry, 1–6.
   Google Scholar
• Tabak, A.G., et al., 2012. Prediabetes: a high-risk state for diabetes development. Lancet (London, England, 379 (9833), 2279–2290.
   PubMed Web of Science ®Google Scholar
• Vasu, S., et al., 2019. MicroRNA signatures as future biomarkers for diagnosis of diabetes states. Cells, 8 (12), 1533.
   PubMed Web of Science ®Google Scholar
• Vienberg, S., et al., 2017. MicroRNAs in metabolism. Acta physiologica (Oxford, England)), 219 (2), 346–361.
   PubMed Web of Science ®Google Scholar
• Vienberg, S., et al., 2017. MicroRNAs in metabolism. Acta physiologica (Oxford, England)), 219 (2), 346–361.
   PubMed Web of Science ®Google Scholar
• Wan, S., et al., 2017. Increased serum miR-7 is a promising biomarker for type 2 diabetes mellitus and its microvascular complications. Diabetes research and clinical practice, 130, 171–179.
   PubMed Web of Science ®Google Scholar
• Wasserman, D.H., Wang, T.J., and Brown, N.J., 2018. The vasculature in prediabetes. Circulation research, 122 (8), 1135–1150.
   PubMed Web of Science ®Google Scholar
• Wild, S., et al., 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care, 27 (5), 1047–1053.
   PubMed Web of Science ®Google Scholar
• Wu, B., and Miller, D., 2017. Involvement of microRNAs in diabetes and its complications. Methods in molecular biology (Clifton, NJ), 1617, 225–239.
   PubMedGoogle Scholar
• Yaribeygi, H., et al., 2018. MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment. Metabolism: clinical and experimental, 87, 48–55.
   PubMed Web of Science ®Google Scholar
• Zhang, N., et al., 2017. Type 2 diabetes mellitus unawareness, prevalence, trends and risk factors: National Health and Nutrition Examination Survey (NHANES) 1999–2010. Journal of international medical research, 45 (2), 594–609.
   PubMed Web of Science ®Google Scholar